Advanced Biomed Inc. (NASDAQ:ADVB) Sees Large Growth in Short Interest

Advanced Biomed Inc. (NASDAQ:ADVB) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totaling 15,397 shares, a growth of 73.5% from the June 15th total of 8,876 shares. Approximately 1.3% of the company’s shares are sold short. Based on an average daily volume of 14,727 shares, the days-to-cover ratio is currently 1.0 days.

Advanced Biomed Price Performance

NASDAQ:ADVB traded up $0.31 during trading hours on Friday, reaching $5.21. 1,666,588 shares of the stock were exchanged, compared to its average volume of 14,556. The stock has a 50-day simple moving average of $4.63. Advanced Biomed has a twelve month low of $3.61 and a twelve month high of $15.20. The stock has a market cap of $8.60 million, a P/E ratio of 1.08 and a beta of 0.52.

Advanced Biomed (NASDAQ:ADVB) last issued its quarterly earnings data on Saturday, May 16th. The company reported ($0.38) earnings per share for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut shares of Advanced Biomed from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, July 8th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.